Biopharmaceutical company focused on the development and commercialization
of therapies to treat endocrine disorders, including human growth
and diabetes.
Stage of Initial
Investment:
Venture
Liquidity:
IPO
(NASDAQ: TRCA)
2000 Sierra Point Parkway, Suite 400
Brisbane, CA 94005
